Stocks · Health care · Pharmaceutical Preparations

XORTX Therapeutics Inc.

XRTX Clue Score34

British Columbia, Canada Fiscal year ends December CIK 0001729214

$1.72 +21.99% Close, 12 Oct 2026

Alert on the numbers Alert on insider trades

Price $1.72 −63.93% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 28 Nov 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.

Net income

	FY2019	FY2020	FY2021
Net income	−0.6	−1.3	−1.7
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.

Operating cash flow

	FY2019	FY2020	FY2021
Operating cash flow	−0.2	−0.7	−6.1

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.

Cash and securities

	FY2019	FY2020	FY2021
Cash and securities	0.1	0.2	18.9
Shareholders’ equity	−0.2	1.3	16.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2021 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.

Click a line to chart it

Fiscal year	FY2019 31 Dec 2019	FY2020 31 Dec 2020	FY2021 31 Dec 2021
Cash & equivalents USD millions	0.1	0.2	18.9
Assets
	0.1	0.2	18.9
	n/a	2.3	22.0
Growth			+862.1%
Liabilities
	n/a	1.0	5.3
Equity
	n/a	−8.0	−9.7
	−0.2	1.3	16.7
Growth			+1,232.4%
Per share and net cash
	n/a	n/a	13.0
calc	n/a	n/a	1.29

Lines marked calc are worked out here from filed figures; point at one for how.